Exclcirc (Suzhou) Biomedical Co., Ltd. rewarded Notification of Passing Preliminary Examination of the Application for Invention from CNIPA on 8 Oct. 2024. The new easy-to-circular universal intron-ribozyme based Scarless circRNA synthesis and purification platform will lead to an easy way for coding and non-coding circular RNA production.